News Summary
The New York Office of Cannabis Management has levied severe penalties against Omnium Health for allowing unlicensed operations within its facilities. The penalties may include multi-million dollar fines and revocation of licenses, following an investigation that uncovered a ‘rent-a-license scheme.’ This crackdown aims to uphold regulatory compliance in the cannabis industry, with potential product recalls affecting millions of dollars worth of goods. The OCM continues to reinforce its commitment to ensuring a transparent and fair cannabis market.
New York – The New York Office of Cannabis Management (OCM) has imposed heavy penalties on Omnium Health, a significant cannabis processing company based in Long Island, following accusations of violating state cannabis licensing laws. The allegations assert that Omnium allowed unlicensed companies to utilize its facilities and distribution channels, a serious breach of regulations intended to ensure a fair and transparent cannabis market.
The repercussions for Omnium Health could be severe, including multi-million dollar fines, the potential revocation of business permits, and an extensive product recall affecting millions of cannabis goods. The OCM’s investigation, which began in February, uncovered a “rent-a-license scheme” where Omnium allegedly leased its premises and operational license to unlicensed operators. One prominent brand involved in this scheme is Mfused, which reportedly rented Omnium’s premises and license to conduct its activities.
Acting Executive Director of the OCM, Felicia Reid, indicated that the actions of Omnium Health undermine the integrity and transparency of the cannabis market. As a result, a formal notice has been filed with an administrative law judge to seek stringent penalties against the company. This includes:
- Revocation of Omnium’s processing and distribution licenses.
- A prohibition on obtaining cannabis permits in the future.
- A civil fine starting at $1 million for selling unauthorized cannabis products.
- A recall of all goods produced by unlicensed processors.
- The destruction of the recalled products.
The specifics of the pending product recall are yet to be determined, pending Omnium’s response to the allegations. However, estimates suggest that the recall could involve a staggering amount of cannabis goods valued at millions of dollars. Additionally, other brands reported to be involved in this investigation include well-known entities such as STIIIZY and Grön.
The OCM has reinforced its commitment to monitoring compliance within the cannabis market, indicating that additional enforcement actions against other firms failing to adhere to regulations may be forthcoming. An initial inspection of Omnium’s facilities was conducted in April, which resulted in a stop-work order and a quarantine of products valued at approximately $10 million.
The industry has reacted to the crackdown with mixed feelings. Some industry leaders praised the OCM’s initiative to uphold safety and compliance standards, while others emphasized that broader issues persist within the cannabis market, describing ongoing practices like “inversion,” where licensed companies utilize illicit out-of-state cannabis products. Moreover, the OCM has previously imposed penalties on Lexachrom Analytical Laboratory, another company that was found to be violating cannabis regulations.
Overall, the actions taken against Omnium Health signify a broader move by regulatory bodies to enforce compliance and promote consumer safety in the rapidly growing cannabis sector. The investigation’s outcomes may lead to lasting changes in operational practices across the industry, ensuring that licensed companies adhere strictly to state mandates designed to regulate the burgeoning market.
Deeper Dive: News & Info About This Topic
HERE Resources
New Regulations for Liquor Licenses in New York State
Empire Cannabis Club Challenges NY Cannabis Regulations
New York Cannabis Lab Lexachrom Faces Severe Penalties
Lawsuit Filed Against New York Cannabis Regulators
Legal Action Initiated Against New York Cannabis Regulators
Second Circuit Deems New York Cannabis Licensing Unconstitutional
Over 100 NYC Cannabis Dispensaries Face Closure Due to Law Misinterpretation
152 Cannabis Retail Businesses at Risk of Closure in New York
New York Cannabis Dispensaries Face Possible Closure Due to Miscalculations
Compliance Crisis Hits New York Cannabis Dispensaries
Additional Resources
- New York Times: Cannabis Omnium
- Wikipedia: Cannabis Industry
- News10: Omnium Health Charges
- Google Search: Omnium Health cannabis charges
- MJBizDaily: New York Punishes Marijuana Distributor
- Encyclopedia Britannica: Cannabis
- Crain’s New York: Omnium Canna Fines
- Google News: Omnium Canna fines
- CBS6 Albany: Charges Against Omnium Canna
- Google Scholar: Cannabis Regulations
Author: STAFF HERE NEW YORK WRITER
The NEW YORK STAFF WRITER represents the experienced team at HERENewYork.com, your go-to source for actionable local news and information in New York, the five boroughs, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as New York Fashion Week, Macy's Thanksgiving Day Parade, and Tribeca Film Festival. Our coverage extends to key organizations like the Greater New York Chamber of Commerce and United Way of New York, plus leading businesses in finance and media that power the local economy such as JPMorgan Chase, Goldman Sachs, and Bloomberg. As part of the broader HERE network, including HEREBuffalo.com, we provide comprehensive, credible insights into New York's dynamic landscape.
